Stockreport

Neoleukin Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference

Neoleukin Therapeutics, Inc.  (NLTX) 
PDF SEATTLE, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational me [Read more]